secwatch.observer — SEC 8-K summary
======================================

Issuer:     ACCENDRA HEALTH INC/VA/ (ACH)
CIK:        0000075252
Form:       8-K
Filed at:   2023-08-04T23:59:59+00:00
Accession:  0000075252-23-000042
Event type: earnings
Sentiment:  negative
Materiality: 0.80
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Owens & Minor Q2 net loss $0.37/share; revenue up 2.5% to $2.56B; adjusted EPS $0.18
--------------------------------------------------------------------------------

- GAAP net loss per share $(0.37) vs prior year $0.37; adjusted EPS $0.18 vs $0.76.
- Revenue $2.56B, up 2.5% YoY; Patient Direct segment double-digit growth drove top line.
- Operating cash flow $313M including $115M receivables sales; net debt reduced $269M.
- Products & Healthcare Services segment saw Global Products headwinds; management cautious on H2 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/75252/000007525223000042/0000075252-23-000042-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/75252/000007525223000042/omi-20230804.htm
  HTML page:      https://secwatch.observer/filing/0000075252-23-000042

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer